Weidong Hu
- Infectious Diseases top 2%
- Molecular Biology
- Pulmonary and Respiratory Medicine top 5%
- Oncology top 10%
- Cancer Research top 5%
- Co-authors
- Sufang TianLi NiuShu‐Yuan XiaoHaibo XuHuan LiuWenhui ZhouLu LvYujin Wang
- Topics
- Lung Cancer Treatments and Mutations (8 papers)Ferroptosis and cancer prognosis (7 papers)Lung Cancer Diagnosis and Treatment (7 papers)
- Partner nations
- ChinaUnited StatesVietnam
In The Last Decade
Weidong Hu
43 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Infectious Diseases 723
- Molecular Biology 538
- Pulmonary and Respiratory Medicine 472
- Oncology 451
- Cancer Research 360
Countries citing papers authored by Weidong Hu
This map shows the geographic impact of Weidong Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weidong Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weidong Hu more than expected).
Fields of papers citing papers by Weidong Hu
This network shows the impact of papers produced by Weidong Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weidong Hu. The network helps show where Weidong Hu may publish in the future.
Co-authorship network of co-authors of Weidong Hu
This figure shows the co-authorship network connecting the top 25 collaborators of Weidong Hu. A scholar is included among the top collaborators of Weidong Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weidong Hu. Weidong Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 12 | |
| 3 | 2 | |
| 4 | 15 | |
| 5 | 34 | |
| 6 | 6 | |
| 7 | Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancerbreakdown → | 989 |
| 8 | 7 | |
| 9 | 8 | |
| 10 | 21 | |
| 11 | 15 | |
| 12 | 64 | |
| 13 | 1 | |
| 14 | 32 | |
| 15 | 27 | |
| 16 | 62 | |
| 17 | 97 | |
| 18 | 2 | |
| 19 | 47 | |
| 20 | 60 |
About Weidong Hu
Weidong Hu is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 44 papers that have together received 1.9k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (8 papers), Ferroptosis and cancer prognosis (7 papers) and Lung Cancer Diagnosis and Treatment (7 papers). The work is most often cited by research in Infectious Diseases (723 citations), Cancer Research (360 citations) and Neurology (356 citations). Weidong Hu has collaborated with scholars based in China, United States and Vietnam. Frequent co-authors include Sufang Tian, Li Niu, Shu‐Yuan Xiao, Haibo Xu, Huan Liu, Wenhui Zhou, Lu Lv, Yujin Wang, Sheng Li and Congkuan Song. Their work appears in journals such as PLoS ONE, Cancer and Journal of Cellular Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.